AKS MEDICAL CONSULTANCY LIMITED
Opportunity 73/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · FRS 105 (micro)Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 105 (micro)| Metric | 2025-05-31 | 2024-05-31 |
|---|---|---|
| Total assets | £-22.5k | £-22.5k |
| Current assets | £14.5k | £284 |
| Net assets | £-22.5k | £-22.5k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 accounts
Corporate timeline (16 events)Click to expand
- 2026-02-19📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-03-03📄accounts-amended-with-accounts-type-micro-entityaccounts · AAMD
- 2024-10-28📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-10-05📄gazette-filings-brought-up-to-dategazette · DISS40
- 2024-10-01📄gazette-notice-compulsorygazette · GAZ1
- 2024-02-29📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-04-21📄accounts-with-accounts-type-dormantaccounts · AA
- 2023-01-23📄change-account-reference-date-company-previous-shortenedaccounts · AA01
- 2022-04-07📄accounts-with-accounts-type-dormantaccounts · AA
- 2021-04-24📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-04-24📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-04-30📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2018-07-18📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2017-04-20📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2012-07-16🏢Company incorporatedAs AKS MEDICAL CONSULTANCY LIMITED
- 2012-07-16➕SHAFIQ, Kamran appointeddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +No director turnover: Company is 14 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- secondary12+ year tenure: Director in role 14 years.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
1 active beneficial owner| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Kamran Shafiq Individual · British · DOB 07/1969 · age 57 | 25–50% | — | 25-50% shares | 06/04/2016 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · LS postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| AESTHETICALLY TRAINED PERSONAL TRAINING LIMITED→ 12441290 · est 2020 · no financials extracted | — | — | — | — | 6y | — | — |
| AICH LIMITED→ 14645296 · est 2023 · no financials extracted | — | — | — | — | 3y | — | — |
| AIM HIGHER HEALTHCARE LIMITED→ 13565884 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| AISLING PSYCHOTHERAPIES LTD→ 14886028 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AK CAPITALS LTD→ 09118350 · est 2014 · no financials extracted | — | — | — | — | 11y | — | — |
| AK RADIOLOGY LEEDS LIMITED→ 12242366 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AK SURGICAL SERVICES LTD→ 15712791 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AKAAD LIMITED→ 15374111 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AKOMENO LTD→ 13340807 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| AKOTO HEALTHCARE SERVICES LTD→ 09515239 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
| AKU MEDICALS LTD→ 16386101 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| AL KHALED HEALTHCARE LTD→ 15952932 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.